The price of innovation: new estimates of drug development costs
Top Cited Papers
- 31 March 2003
- journal article
- Published by Elsevier BV in Journal of Health Economics
- Vol. 22 (2), 151-185
- https://doi.org/10.1016/s0167-6296(02)00126-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Link Between Gross Profitability And Pharmaceutical R&D SpendingHealth Affairs, 2001
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical FirmsDrug Information Journal, 2000
- The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee EraDrug Information Journal, 2000
- Chapter 25 The pharmaceutical industryPublished by Elsevier BV ,2000
- R&D Costs, Innovative Output and Firm Size in the Pharmaceutical IndustryInternational Journal of the Economics of Business, 1995
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 1990